Bluejay Diagnostics Files 2024 Annual Report

Ticker: BJDX · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1704287

Bluejay Diagnostics, INC. 10-K Filing Summary
FieldDetail
CompanyBluejay Diagnostics, INC. (BJDX)
Form Type10-K
Filed DateMar 31, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: annual-report, 10-K, medical-devices

TL;DR

Bluejay Diagnostics filed its 2024 10-K. All systems go for review.

AI Summary

Bluejay Diagnostics, Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2024. The company, incorporated in Delaware with its principal executive offices in Acton, MA, operates in the Surgical & Medical Instruments & Apparatus industry. The filing covers its operations and financial status as of March 31, 2025.

Why It Matters

This 10-K filing provides investors and stakeholders with a comprehensive overview of Bluejay Diagnostics' financial performance, business operations, and risk factors for the fiscal year 2024.

Risk Assessment

Risk Level: medium — As a medical device company, Bluejay Diagnostics faces inherent risks related to product development, regulatory approvals, market adoption, and competition.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Bluejay Diagnostics, Inc.?

Bluejay Diagnostics, Inc. operates in the Surgical & Medical Instruments & Apparatus industry, as indicated by its SIC code 3841.

When did Bluejay Diagnostics, Inc. file its annual report?

The company filed its Form 10-K on March 31, 2025.

For which fiscal year is this 10-K report?

This report is for the fiscal year ended December 31, 2024.

Where are Bluejay Diagnostics, Inc.'s principal executive offices located?

The principal executive offices are located at 360 Massachusetts Avenue, Suite 203, Acton, MA 01720.

What is the company's state of incorporation?

Bluejay Diagnostics, Inc. is incorporated in Delaware.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Bluejay Diagnostics, Inc. (BJDX).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing